Bath & Body Works (NYSE:BBWI) Stock Price Expected to Rise, Deutsche Bank Aktiengesellschaft Analyst Says

Bath & Body Works (NYSE:BBWI) had its target price upped by equities researchers at Deutsche Bank Aktiengesellschaft from $21.00 to $22.00 in a research report issued to clients and investors on Tuesday,MarketScreener reports. The brokerage presently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s target price points to a potential upside of 3.16% from the stock’s previous close.

A number of other research analysts have also recently issued reports on BBWI. Wells Fargo & Company cut their target price on shares of Bath & Body Works from $33.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday, November 21st. Telsey Advisory Group raised their price target on Bath & Body Works from $17.00 to $23.00 and gave the company a “market perform” rating in a report on Friday. The Goldman Sachs Group lowered Bath & Body Works from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $39.00 to $17.00 in a research note on Thursday, November 20th. Bank of America set a $26.00 target price on Bath & Body Works in a report on Monday, November 24th. Finally, JPMorgan Chase & Co. cut their price target on Bath & Body Works from $26.00 to $15.00 and set a “neutral” rating for the company in a report on Thursday, November 20th. Three equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $23.86.

Bath & Body Works Trading Down 3.2%

Shares of Bath & Body Works stock traded down $0.71 during mid-day trading on Tuesday, reaching $21.33. 279,438 shares of the stock were exchanged, compared to its average volume of 4,907,622. Bath & Body Works has a fifty-two week low of $14.27 and a fifty-two week high of $35.21. The company has a market cap of $4.37 billion, a price-to-earnings ratio of 6.56, a price-to-earnings-growth ratio of 1.00 and a beta of 1.54. The firm has a 50-day simple moving average of $22.19 and a 200 day simple moving average of $23.63.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. MidFirst Bank acquired a new position in Bath & Body Works during the 4th quarter worth approximately $51,000. Kera Capital Partners Inc. grew its stake in Bath & Body Works by 68.3% in the fourth quarter. Kera Capital Partners Inc. now owns 13,891 shares of the company’s stock valued at $303,000 after acquiring an additional 5,638 shares during the period. Invesco Ltd. increased its holdings in shares of Bath & Body Works by 43.6% during the fourth quarter. Invesco Ltd. now owns 652,991 shares of the company’s stock valued at $13,112,000 after acquiring an additional 198,324 shares in the last quarter. Corient Private Wealth LLC increased its holdings in shares of Bath & Body Works by 475.8% during the fourth quarter. Corient Private Wealth LLC now owns 97,202 shares of the company’s stock valued at $1,952,000 after acquiring an additional 80,322 shares in the last quarter. Finally, Alberta Investment Management Corp acquired a new position in shares of Bath & Body Works during the fourth quarter worth approximately $1,135,000. 95.14% of the stock is currently owned by institutional investors and hedge funds.

More Bath & Body Works News

Here are the key news stories impacting Bath & Body Works this week:

• Positive Sentiment: Analyst target upgrades and valuation checks provide limited support—Barclays raised its target from $20 to $21 (equal‑weight), and another outlet reported a $23 target, suggesting some analysts see upside or improved fundamentals. These are modestly positive but not decisive given contrasting news. Benzinga Price Target to $23
• Neutral Sentiment: Media pieces preview earnings and examine valuation and a seasonal collaboration (Peeps) that may help spring sales — useful for fundamental/earnings context but unlikely to move the stock strongly on their own. Earnings Preview Valuation Check
• Negative Sentiment: Multiple law firms announced or reminded investors of securities‑fraud class actions covering purchases between June 4, 2024 and November 19, 2025, and set imminent lead‑plaintiff deadlines. The proliferation of filings and firm outreach raises legal risk, potential costs, and investor uncertainty. Representative notices include filings and reminders from The Gross Law Firm and Portnoy Law Firm. Gross Law Firm Notice Portnoy Law Firm
• Negative Sentiment: Large institutional selling: Cooper Creek liquidated a ~5.0M‑share stake in Q4, cutting a position worth about $129M at quarter end. The sale increases share supply and signals at least one large investor reducing exposure after a weak quarter and outlook, which is typically bearish. Fool Coverage

About Bath & Body Works

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.